CD14 and toll-like receptor 4: A link between infection and acute coronary events?

Heart

Volumn 90, Issue 9, 2004, Pages 983-988

  Arroyo Espliguero, R ^b   Avanzas, P ^c   Jeffery, S ^a   Kaski, J C ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 4;

ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; GENETIC POLYMORPHISM; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFECTION; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW;

ANTIGENS, CD14; CELL COMMUNICATION; CORONARY ARTERIOSCLEROSIS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MEMBRANE GLYCOPROTEINS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 4344648938     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2002.001297     Document Type: Review

References (77)

1. Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999;100:e20-8.
2. Liao W. Endotoxin: possible roles in initiation and development of atherosclerosis. J Lab Clin Med 1996;128:452-60.
3. Wight SD, Ramos RA, Tobias PS, et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431-3.
4. Ulevitch RJ, Tobias PS. Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 1999;11:19-22.
5. Beekhuizen H, Blokland I, Corsel-van Tilburg A, et al. CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells. J Immunol 1991;147:3761-7.
6. Heidenreich S, Schmidt M, August C, et al. Regulation of human monocyte apoptosis by the CD14 molecule. J Immunol 1997;159:3178-88.
7. Frey EA, Finlay BB. Lipopolysaccharide induces apoptosis in a bovine endothelial cell line via a soluble CD14 dependent pathway. Microb Pathog 1998;24:101-9.
8. LeVan TD, Bloom JW, Bailey TJ, et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 2001;167:5838-44.
9. Arbour NC, Lorenz E, Schutte BC. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187-91.
10. Unkelbach K, Gardemann A, Kostrzewa M, et al. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscelr Thromb Vasc Biol 1999;19:932-8.
11. Ameziane N, Beillat T, Verpillat P, et al. Association of the toll-like receptor 4 Asp299Gly polymorphism with acute coronary syndromes. Arterioscler Thromb Vasc Biol 2003;23:e61-4.
12. Ferrero E, Goyert SM. Nucleotide sequence of the gene encoding the monocyte differentiation antigen, CD14. Nucl Acids Res 1988;16:4173.
13. Haziot A, Chen S, Ferrero E, et al. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 1988;141:547-52.
14. Goyert SM, Ferrero EM, Seremetis SV, et al. Biochemistry and expression of myelomonocytic antigens. J Immunol 1986;137:3909-14.
15. Ziegler-Heitbrock HW, Ulevitch RJ. CD14: cell surface receptor and differentiation marker. Immunol Today 1993;14:121-5.
16. Antal-Szalmás P. Evaluation of CD14 in host defense. Eur J Clin Invest 2000;30:167-79.
17. Zajchowski LD, Robbins SM. Lipid rafts and little caves: compartmentalized signalling in membrane microdomains. Eur J Biochem 2002;269:737-52.
18. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev 2000;1:31-41.
19. Simionescu N. Cellular aspects of transcapillary exchange. Physiol Rev 1983;63:1536-79.
20. Anderson RG, Kamen BA, Rothberg KG, et al. Potocytosis: sequestration and transport of small molecules by caveolea. Science 1992;255:410-1.
21. Okamoto T, Schlegel A, Scherer PE, et al. Caveolins, a family of scaffolding proteins for organizing 'pre-assembled signaling complexes' at the plasma membranes. J Biol Chem 1998;273:5419-22.
22. Labeta MO, Durieux JJ, Fernández N, et al. Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14. Eur J Immunol 1993;23:2144-51.
23. Le-Barillec K, Si-Tahar M, Balloy V, et al. Proteolysis of monocyte CD14 by human leukocyte elastase inhibits lipopolysaccharide-mediated cell activation. J Clin Invest 1999;103:1039-46.
24. Loppnow H, Stelter F, Schonbeck U, et al. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infect Immun 1995;63:1020-6.
25. Hailman E, Lichenstein HS, Wurfel MM, et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 1994;179:269-77.
26. Lamping N, Dettmer R, Schroder NW, et al. LPS-binding protein protects mice from septic shock caused by LPS of gram-negative bacteria. J Clin Invest 1998;101:2065-71.
27. Tobias PS, Soldau K, Gegner JA, et al. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J Biol Chem 1995;270:10482-8.
28. Cunningham MD, Shapiro RA, Seachord C, et al. CD14 employs hydrophilic regions to "capture" lipopolysaccharides. J Immunol 2000;164:3255-63.
29. Lee JD, Kravchenko V, Kirkland TN, et al. Glycosyl-phosphatidylinositol- anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc Natl Acad Sci USA 1993;90:9930-4.
30. Poltorak A, He X, Smirnova I, et al. Defective LPS signalling in C3H/HeJ and C57BL/10ScCR mice: mutation in TLR4 gene. Science 1998;282:2085-8.
31. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the drosophila toll protein signals activation of adaptive immunity. Nature 1997;388:394-7.
32. O'Neill LA. The interleukin-1 receptor/toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2000;2000:RE1.
33. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacteria cell wall components. Immunity 1999;11:443-51.
34. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001;13:85-94.
35. Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-71.
36. Yang H, Young DW, Gusovsky F, et al. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1. J Biol Chem 2000;275:20861-6.
37. Visintin A, Mazzoni A, Spitzer JA, et al. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to toll-like receptor 4. Proc Natl Acad Sci USA 2001;98:12156-61.
38. Akashi S, Ogata H, Kirikae T, et al. Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2. Biochem Biophys Res Commun 2000;268:172-7.
39. da Silva J, Ulevitch RJ. MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J Biol Chem 2002;277:1845-54.
40. Savedra R Jr, Delude RL, Ingalls RR, et al. Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system. J Immunol 1996;157:2549-54.
41. Sellati TJ, Bouis DA, Kitchens RL, et al. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-depenaent pathway distinct from that used by lipopolysaccharide. J Immunol 1998;160:5455-64.
42. Dziarski R, Tapping RI, Tobias PS. Binding of bacterial peptidoglycan to CD14. J Biol Chem 1998;273:8680-90.
43. Klein BS. Role of cell surface molecules of Blastomyces dermatidis in the pathogenesis and immunobiology of blastomycosis. Semin Respir Infect 1997;12:198-205.
44. Kol A, Lichtman AH, Finberg RW, et al. Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol 2000;164:13-7.
45. Bulut Y, Faure E, Thomas L, et al. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol 2002;168:1435-40.
46. Dybdahl B, Wahba A, Lien E, et al. Inflammatory response after open heart surgery: release of heat-shock protein 70 and signalling through toll-like receptor-4. Circulation 2002;105:685-90.
47. Gao B, Tsan MF. Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor α from murine macrophages. J Biol Chem 2003;278:22523-9.
48. Lauener RD, Geha RS, Vercelli D. Engagement of the monocyte surface antigen CD14 induces lymphocyte function-associated antigen-1/intercellular adhesion molecule-1-dependent homotypic adhesion. J Immunol 1990;145:1390-4.
49. Wright SD, Ramos RA, Hermanowski-Vosatka S, et al. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J Exp Med 1991;173:1281-6.
50. Beekhuizen H, Blokland I, van Furth R. Cross-linking of CD14 molecules on monocytes results in a CD11/CD18- and ICAM-1-dependent adherence to cytokine-stimulated human endothelial cells. J Immunol 1993;150:950-9.
51. Maulik N, Goswami S, Galang N, et al. Differential regulation of Bcl-2, AP-1, and NF-κB on cardiomyocyte apoptosis during myocardial ischemic stress adaptation. FEBS Lett 1999;443:331-6.
52. Liston P, Roy N, Tamai K, et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 1996;379:349-53.
53. Hida A, Kawakami A, Nakashima T, et al. Nuclear foctor-kappaB and caspases co-operatively regulate the activation and apoptosis of human macrophages. Immunology 2000;99:553-60.
54. Heidenreich S. Monocyte CD14: multifunctional receptor engaged in apoptosis from both sides. J Leukoc Biol 1999;65:737-43.
55. Messmer UK, Pfeilschifter J. New insights into the mechanism for clearance of apoptotic cells. BioEssays 2000;22:878-81.
56. Devitt A, Moffatt OD, Raykundalia C, et al. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998;392:505-9.
57. Heidenreich S. Monocyte CD14: a multifunctional receptor engaged in apoptosis from both sides. J Leukoc Biol 1999;65:737-43.
58. Zalai CV, Koloziejczyk MD, Pilarski L, et al. Increased circulating monocyte activation in patients with unstable coronary syndromes. J Am Coll Cardiol 2001;38:1340-7.
59. Lee WH, Lee Y, Jeong JO, et al. Activation of CD14 on circulating monocytes in patients with acute coronary syndromes. Int J Cardiol 2001;80:135-42.
60. Palusinski RP, Vaisman D, Pasceri V, et al. Synergy between CD14 and C-reactive protein (CRP) in endothelial cell activation. Circulation 2002;106(suppl II):533-4.
61. Baldini M, Lohman IC, Halonen M, et al. A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999;20:976-83.
62. Hubacek JA, Pit'ha J, Škodová Z, et al. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999;99:3218-20.
63. Shimada K, Watanabe Y, Mokuno H, et al. Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men. Am J Cardiol 2000;86:682-4.
64. Hohda S, Kimura A, Sasaoka T, et al. Association study of CD14 polymorphism with myocardial infarction in a Japanese population. Jpn Heart J 2003;44:613-22.
65. Arroyo-Espliguero R, El-Sharnouby K, Vázquez-Rey E, et al. CD14 C(-260)T polymorphism and prevalence of acute coronary syndromes. Int J Cardiol 2004. (in press).
66. Kondo T, Ohno M, Shimokata K, et al. CD14 promoter polymorphism is associated with acute myocardial infarction resulting from insignificant coronary artery stenosis. Heart 2003;89:931-2.
67. Koch W, Kastrati A, Mehilli J, et al. CD14 gene-159C/T polymorphism is not associated with coronary artery disease and myocardial infarction. Am Heart J 2002;143:971-6.
68. Zee RYL, Lindpaintner K, Struk B, et al. A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction. Atherosclerosis 2001;154:699-702.
69. Nauck M, Winkelmann BR, Hoffmann MM, et al. C(-260)T polymorphism in the promoter of the CD14 gene is not associated with coronary artery disease and myocardial infarction in the Ludwigshafen risk and cardiovascular health (LURIC) study. Am J Cardiol 2002;90:1249-52.
70. Longobardo MT, Cefalú AB, Pezzino F, et al. The C(-260)T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction. Clin Exp Med 2003;3:161-5.
71. Andreotti F, Porto I, Crea F, et al. Inflammatory gene polymorphism and ischaemic heart disease: review of population association studies. Heart 2002;87:107-12.
72. Chandra HR, Choudhary N, O'Neill C, et al. Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndromes (CIMACS). Am J Cardiol 2001;88:214-8.
73. Xu XH, Shah PK, Faure E, et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerosis plaques and upregulated by oxidized LDL. Circulation 2001;104:3103-8.
74. Liuzzo G, Angiolillo DJ, Buffon A, et al. Enhanced response of blood monocytes to in vitro lipopolysaccharide-challenge in patients with recurrent unstable angina. Circulation 2001;103:2236-41.
75. Biasucci LM, Liuzzo G, Ciervo A, et al. Antibody response to chlamydia heat shock protein 60 is strongly associated with acute coronary syndromes. Circulation 2003;107:3015-7.
76. Kiechl S, Lorenz E, Reindl M, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002;347:185-92.
77. Kiechl S, Wiedermann CJ, Willeit J. Toll-like receptor 4 and atherogenesis. Ann Med 2003;35:164-71.